Non-peptidic glucose-like peptide-1 receptor agonists: aftermath of a serendipitous discovery

Role and development of GLP-1 receptor agonists in the management of diabetes

(2016) Josephine Egan et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Pharmacokinetics and tolerability of a novel long-acting glucagon-like peptide-1 analog, CJC-1131, in healthy and diabetic subjects

(2011) R.G. Tiessen et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Prevalence of Diabetes among Men and Women in China

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence of Diabetes among Men and Women in China

(2010) Wenying Yang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Type 2 Diabetes: An Expanded View of Pathophysiology and Therapy

(2010) Jeff Unger et al.   POSTGRADUATE MEDICINE

New Perspectives in Type 2 Diabetes, Cardiovascular Risk, and Treatment Goals

(2010) Carol H. Wysham   POSTGRADUATE MEDICINE

Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide

(2009) Renate E. van Genugten et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors

(2009) Joshua J. Neumiller   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis

(2008) Laurie L. Baggio et al.   GASTROENTEROLOGY

Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain

(2008) Steffen Runge et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists

(2008) Fu Lin et al.   JOURNAL OF MOLECULAR MODELING

Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice

(2008) Haoran Su et al.   PLoS One